Historical perspective: early observations on the lupus anticoagulantGOLDSMITH, G. H. JR.The Journal of laboratory and clinical medicine. 1987, Vol 110, Num 2, issn 0022-2143, 250Article

Bovine coronary artery endothelium: in vitro culture and production of plasminogen activatorZIATS, N. P; GOLDSMITH, G. H; MEDVEDEFF, E. D et al.Thrombosis research. 1986, Vol 41, Num 2, pp 239-250, issn 0049-3848Article

Antiphospholipid antibody : functional specificity for inhibition of prothrombin activation by the prothrombinase complexPIERANGELI, S. S; GOLDSMITH, G. H; BRANCH, D. W et al.British journal of haematology. 1997, Vol 97, Num 4, pp 768-774, issn 0007-1048Article

Studies on the interaction of placental anticoagulant protein I, β₂glycoprotein 1, and antiphospholipid antibodies in the prothrombinase reaction and in the solid phase anticardiolipin assaysPIERANGELI, S. S; DEAN, J; GOLDSMITH, G. H et al.The Journal of laboratory and clinical medicine. 1996, Vol 128, Num 2, pp 194-201, issn 0022-2143Article

Phase I study of paclitaxel and day 1/day 8 gemcitabine in patients with solid malignanciesFLEMING, D. R; GLISSON, S. D; BHUPALAM, L et al.American journal of clinical oncology. 2000, Vol 23, Num 4, pp 349-352, issn 0277-3732Article

Differences in functional activity of anticardiolipin antibodies from patients with syphilis and those with antiphospholipid syndromePIERANGELI, S. S; GOLDSMITH, G. H; KRNIC, S et al.Infection and immunity. 1994, Vol 62, Num 9, pp 4081-4084, issn 0019-9567Article

Modulation of polymorphonuclear leukocyte microbicidal activity and oxidative metabolism by fibrinogen degradation products D and EKAZURA, J. W; WENGER, J. D; SALATA, R. A et al.The Journal of clinical investigation. 1989, Vol 83, Num 6, pp 1916-1924, issn 0021-9738Article

The quality of medical evidence in hematology-oncologyDJULBEGOVIC, B; LOUGHRAN, T. P; HORNUNG, C. A et al.The American journal of medicine. 1999, Vol 106, Num 2, pp 198-205, issn 0002-9343Article

Neutrophil adhesive dysfunction in diabetes mellitus : the role of cellular and plasma factorsANDERSEN, B; GOLDSMITH, G. H; SPAGNUOLO, P. J et al.The Journal of laboratory and clinical medicine. 1988, Vol 111, Num 3, pp 275-285, issn 0022-2143Article

Metal and phospholipids binding properties of partially carboxylated human prothrombin variantsBOROWSKI, M; FURIE, B. C; GOLDSMITH, G. H et al.The Journal of biological chemistry (Print). 1985, Vol 260, Num 16, pp 9258-9264, issn 0021-9258Article

Escalating doses of sequential methotrexate and 5-fluorouracil, doxorubicin, and vincristine for the treatment of metastatic breast cancerSPITZER, T. R; GOLDSMITH, G. H. JR; LAZARUS, H. M et al.American journal of clinical oncology. 1987, Vol 10, Num 6, pp 483-484, issn 0277-3732Article

Studies on a circulating anticoagulant inhibiting factor XI in a patient with congenital deficiency and carcinoma of the prostateCHEDIAK, J; MADEJ-ZEVIN, P; RATNOFF, O. D et al.British journal of haematology. 1986, Vol 63, Num 1, pp 123-133, issn 0007-1048Article

A monoclonal antibody that inhibits activation of human Hageman factor (factor XII)SMALL, E. J; KATZMAN, J. A; TRACY, R. P et al.Blood. 1985, Vol 65, Num 1, pp 202-210, issn 0006-4971Article

Primary pulmonary hypertension in patients with classic hemophiliaGOLDSMITH, G. H. JR; BAILY, R. G; BRETTLER, D. B et al.Annals of internal medicine. 1988, Vol 108, Num 6, pp 797-799, issn 0003-4819Article